Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 35, 2015, Pages 11030-11035

  Massoud, Raya ^a   Enose Akahata, Yoshimi ^a   Tagaya, Yutaka ^b   Azimi, Nazli ^c   Basheer, Asjad ^c   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Bioniz   (United States)

Author keywords

Gamma chain; HAM TSP; Human T cell lymphotropic virus type 1; IL 15

Indexed keywords

BNZ 132 1; BNZ 132 1 40; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 15; INTERLEUKIN 2; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PEPTIDE;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TROPICAL SPASTIC PARAPARESIS; DEGRANULATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE;

BIOMARKERS; CELL DEGRANULATION; HUMANS; IN VITRO TECHNIQUES; PARAPARESIS, TROPICAL SPASTIC; PEPTIDES; T-LYMPHOCYTES;

EID: 84941004629     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1412626112     Document Type: Article

References (24)

1. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058-6068.
2. Araujo AQ, Silva MT (2006) The HTLV-1 neurological complex. Lancet Neurol 5(12):1068-1076.
3. Lima MA, Harab RC, Schor D, Andrada-Serpa MJ, Araújo AQ (2007) Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 13(5):468-473.
4. Umehara F, et al. (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52(4):424-430.
5. Aye MM, et al. (2000) Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: Inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol 100(3):245-252.
6. Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S (2001) In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: Predominant expansion of CD8+ T cells. Blood 98(5):1506-1511.
7. Yamano Y, et al. (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99(1):88-94.
8. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348(6298):245-248.
9. Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (1998) Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161(1):482-488.
10. Johnson-Nauroth JM, Graber J, Yao K, Jacobson S, Calabresi PA (2006) Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol 176(1-2):115-124.
11. Yamane H, Paul WE (2012) Cytokines of the γ(c) family control CD4+ T cell differentiation and function. Nat Immunol 13(11):1037-1044.
12. Liao W, Lin JX, Leonard WJ (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38(1):13-25.
13. Verbist KC, Klonowski KD (2012) Functions of IL-15 in anti-viral immunity: Multiplicity and variety. Cytokine 59(3):467-478.
14. Azimi N, Jacobson S, Leist T, Waldmann TA (1999) Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 163(7):4064-4072.
15. Lehky TJ, et al. (1998) Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol 44(6):942-947.
16. Ju W, et al. (2011) CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. Blood 117(6):1938-1946.
17. Salgado E, Maneiro JR, Carmona L, Gomez-Reino JJ (2014) Safety profile of protein kinase inhibitors in rheumatoid arthritis: Systematic review and meta-analysis. Ann Rheum Dis 73(5):871-882.
18. Azimi N, Nagai M, Jacobson S, Waldmann TA (2001) IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci USA 98(25):14559-14564.
19. Enose-Akahata Y, Oh U, Grant C, Jacobson S (2008) Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood 112(6):2400-2410.
20. Peloponese JM, Yeung ML, Jeang KT (2006) Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: Implications for oncogenesis and inflammation. Immunol Res 34(1):1-12.
21. Chen J, et al. (2008) Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. Blood 111(10):5163-5172.
22. Abadie V, Discepolo V, Jabri B (2012) Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol 34(4):551-566.
23. Dunphy S, Gardiner CM (2011) NK cells and psoriasis. J Biomed Biotechnol 2011:248317.
24. Tefferi A, et al. (2011) Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study. J Clin Oncol 29(10):1356-1363.